Warberg Asset Management’s Humacyte Inc Warrant HUMAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-35,662
Closed -$103K 209
2021
Q3
$103K Buy
+35,662
New +$104K 0.02% 134

Other funds holding HUMAW

Warberg Asset Management's HUMAW Position: Q4 2021 in Review

Warberg Asset Management sold out of Humacyte Inc Warrant (HUMAW) in Q4 2021, closing a stake of 35,662 shares — an estimated $103K sold.

Warberg Asset Management first reported a position in HUMAW in Q3 2021 and held it in 1 quarter. The position peaked at $103K in Q3 2021. 15 funds tracked by Wall St. Rank hold HUMAW as of Q4 2021.

  • Warberg Asset Management reported no remaining Humacyte Inc Warrant position as of Q4 2021 after selling out during the quarter.
  • Warberg Asset Management sold 35,662 Humacyte Inc Warrant shares in Q4 2021, an estimated $103K.
  • Warberg Asset Management first reported a position in Humacyte Inc Warrant in Q3 2021 and held it in 1 quarter.
  • Warberg Asset Management's Humacyte Inc Warrant position peaked at $103K in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q4 2021.

Based on Warberg Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.